KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for AbCellera Biologics (ABCL) over the last 6 years, with Q3 2025 value amounting to $133.0 million.

  • AbCellera Biologics' Prepaid Assets rose 20668.42% to $133.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.0 million, marking a year-over-year increase of 20668.42%. This contributed to the annual value of $67.1 million for FY2024, which is 2030.1% up from last year.
  • As of Q3 2025, AbCellera Biologics' Prepaid Assets stood at $133.0 million, which was up 20668.42% from $116.8 million recorded in Q2 2025.
  • In the past 5 years, AbCellera Biologics' Prepaid Assets ranged from a high of $133.0 million in Q3 2025 and a low of $5.7 million during Q1 2021
  • In the last 5 years, AbCellera Biologics' Prepaid Assets had a median value of $55.8 million in 2023 and averaged $56.7 million.
  • As far as peak fluctuations go, AbCellera Biologics' Prepaid Assets soared by 60081.39% in 2022, and later crashed by 4301.25% in 2024.
  • Over the past 5 years, AbCellera Biologics' Prepaid Assets (Quarter) stood at $21.2 million in 2021, then skyrocketed by 254.93% to $75.4 million in 2022, then dropped by 25.99% to $55.8 million in 2023, then grew by 20.3% to $67.1 million in 2024, then soared by 98.11% to $133.0 million in 2025.
  • Its last three reported values are $133.0 million in Q3 2025, $116.8 million for Q2 2025, and $94.7 million during Q1 2025.